Improving Advance Care Planning by Care Partners of Persons Living With Dementia Using a Narrative Video Game (ANTICIPATE)
The primary objective of this study is to evaluate the feasibility of using a narrative video game intervention to improve advance care planning (ACP) among care partners of people living with Alzheimer's Disease and Related Dementia. Feasibility will be assessed by evaluating acceptability as well as the fidelity of intervention delivery.
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
Gedetailleerde beschrijving
The trial is designed to establish the feasibility and plausibility of using the intervention to alter psychological outcomes, necessary to justify a future Type 1 hybrid effectiveness-implementation trial.
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Fase
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
Studiecontact
- Naam: Deepika Mohan, MD, MPH
- Telefoonnummer: 412-647-0835
- E-mail: mohand@upmc.edu
Studie Contact Back-up
- Naam: Caroline J Pidro
- Telefoonnummer: 412-383-0821
- E-mail: cjl13@pitt.edu
Studie Locaties
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15213
- University of Pittsburgh
-
Contact:
- Deepika Mohan, MD, MPH
- Telefoonnummer: 412-647-0835
- E-mail: mohand@upmc.edu
-
Contact:
- Caroline J Pidro
- Telefoonnummer: 412-383-0821
- E-mail: cjl13@pitt.edu
-
Hoofdonderzoeker:
- Deepika Mohan, MD, MPH
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Be 18 years or older
- Identify as the primary support person (care partner) for health-related decisions for a person with dementia
Exclusion Criteria:
- the person with dementia has died
- the care partner does not have an email address
- the care partner is unwilling to be recorded
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Aantal wapens
Wapens en interventies
Deelnemersgroep / ArmDeelnemersgroep / Arm |
Interventie / BehandelingInterventie / Behandeling |
|---|---|
|
Experimenteel: Pre and Post Intervention (Narrative Video Game) Assessment
Participants in this arm will complete the Surrogate ACP Readiness Survey prior to intervention exposure. Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
Andere namen:
|
|
Experimenteel: Post-Intervention (Narrative Video Game) Assessment Only
Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Acceptability of the intervention (co-primary)
Tijdsspanne: Immediately following intervention exposure
|
Proportion of participants who score the intervention as ≥4/5 on the Acceptability of Intervention Measure |
Immediately following intervention exposure
|
|
Fidelity of intervention delivery (co-primary)
Tijdsspanne: 3 months post-intervention exposure
|
Proportion of participants who complete all study tasks |
3 months post-intervention exposure
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Fidelity of intervention receipt
Tijdsspanne: Pre-intervention to 3 months post-intervention
|
Mean responses to the items on the ACP Engagement Survey for Surrogate Decision makers and then summarized by domain (knowledge, readiness, self-efficacy, contemplation). |
Pre-intervention to 3 months post-intervention
|
|
Fidelity of intervention enactment (self-reported completion of ACP)
Tijdsspanne: 3 months post-intervention
|
Proportion of participants who report ACP activities after intervention exposure |
3 months post-intervention
|
|
Fidelity of behavior change technique delivery
Tijdsspanne: Immediately post-intervention
|
Proportion of participants who report the use of behavioral rehearsal during the game or who demonstrate the use of rehearsal during game play. |
Immediately post-intervention
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Medewerkers
Medewerkers
Onderzoekers
Onderzoekers
- Hoofdonderzoeker: Amber Barnato, MD, MPH, MS, Dartmouth College
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
Andere studie-ID-nummers
- STUDY26060072
- R21AG098846 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
All collected and de-identified individual participant data.
IPD-tijdsbestek voor delen
It will be made available within 6 months of completion of the study, and will be available for 7 years.
IPD-toegangscriteria voor delen
We will upload the data to a data repository (ICPSR), and researchers may access it by following the protocols set by the repository.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ANALYTIC_CODE
- MVO
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .